Compare IOVA & CVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IOVA | CVE |
|---|---|---|
| Founded | 2007 | 2009 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 968.6M | 34.6B |
| IPO Year | N/A | N/A |
| Metric | IOVA | CVE |
|---|---|---|
| Price | $2.21 | $18.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 2 |
| Target Price | $10.45 | ★ $26.00 |
| AVG Volume (30 Days) | ★ 12.5M | 11.3M |
| Earning Date | 02-26-2026 | 02-19-2026 |
| Dividend Yield | N/A | ★ 3.05% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.23 |
| Revenue | $250,425,000.00 | ★ $37,063,946,178.00 |
| Revenue This Year | $60.71 | N/A |
| Revenue Next Year | $59.52 | N/A |
| P/E Ratio | ★ N/A | $14.95 |
| Revenue Growth | ★ 175.62 | N/A |
| 52 Week Low | $1.64 | $10.23 |
| 52 Week High | $6.50 | $18.75 |
| Indicator | IOVA | CVE |
|---|---|---|
| Relative Strength Index (RSI) | 40.57 | 60.29 |
| Support Level | $2.29 | $15.63 |
| Resistance Level | $2.80 | $18.67 |
| Average True Range (ATR) | 0.18 | 0.55 |
| MACD | -0.06 | 0.20 |
| Stochastic Oscillator | 1.30 | 82.75 |
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
Cenovus Energy Inc is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 786 thousand barrels of oil equivalent per day in 2022. The company had upstream projects across Western Canada; crude oil production and natural gas and NGLs production offshore China and Indonesia. The downstream operations include upgrading and refining operations in Canada and the U.S., and commercial fuel operations across Canada.